Showing results (571-580 of 1,180) with videos related to

Sort By:
Pageof 118
Pharmacogenomics|September 20, 2006
Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenomaRoxana Moslehi, Nilanjan Chatterjee, Timothy R Church, et al.
Primary Care Diabetes|July 21, 2018
Prior antibiotic exposure and risk of type 2 diabetes among VeteransP Jordan Davis, Mengling Liu, Farrokh Alemi, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|May 26, 2018
Intervention Fidelity Within Trials of Infant Feeding Behavioral Interventions to Prevent Childhood Obesity: A Systematic ReviewElaine Toomey, Karen Matvienko-Sikar, Caroline Heary, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 24, 2006
High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection programUlrike Peters, Nilanjan Chatterjee, Timothy R Church, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 16, 2007
Variant in sex hormone-binding globulin gene and the risk of prostate cancerSonja I Berndt, Nilanjan Chatterjee, Wen-Yi Huang, et al.
Cytogenetic and Genome Research|December 28, 2007
The molecular basis of the folate-sensitive fragile site FRA11A at 11q13K Debacker, B Winnepenninckx, C Longman, et al.
Animal Genetics|May 27, 2009
Characterization of a QTL region affecting clinical mastitis and protein yield on BTA6H Nilsen, H G Olsen, B Hayes, et al.
The New England Journal of Medicine|February 14, 2009
B-cell clones as early markers for chronic lymphocytic leukemiaOla Landgren, Maher Albitar, Wanlong Ma, et al.
Plos One|March 26, 2016
Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer InterrelationsRashmi Sinha, Jiyoung Ahn, Joshua N Sampson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2009
Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacyC Kollmannsberger, C Moore, K N Chi, et al.
Pageof 118